Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Platelet-Rich Plasma for Vulvar Lichen Sclerosus
NCT04967170Phase 2Completed
- Start
- Jan 2022
- Primary completion
- Dec 2025
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of autologous platelet-rich plasma in vulvar lichen sclerosus (LS). Started Jan 2022; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT04967170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04967170.